Neurofeedback for Healthy Subjects
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new behavioral treatment using real-time brain scans to understand and manage threat expectations. The treatment involves neurofeedback, where participants receive real-time feedback on their brain activity, focusing on the connection between the prefrontal cortex and the hippocampus. Participants will receive either actual neurofeedback (Active Real-time fMRI Neurofeedback) or a sham version to compare results. Suitable candidates are healthy adults with no history of brain or psychiatric disorders, not taking mind-altering medications, and able to undergo an MRI scan. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research in understanding brain function and behavioral treatment.
Will I have to stop taking my current medications?
If you are currently taking psychoactive medication or drugs of abuse, you will need to stop taking them to participate in this trial.
What prior data suggests that this neurofeedback intervention is safe for healthy adults?
Research has shown that real-time fMRI neurofeedback is generally well-tolerated. This treatment uses brain scans to provide feedback, helping individuals learn to control certain brain activities. In about 25% to 50% of cases, participants successfully change their brain activity using this method.
Although information on side effects is limited, the technology is non-invasive, meaning it doesn't involve surgery or entering the body, and is usually considered safe. Most reports have not mentioned any serious side effects. However, as with any treatment, experiences can vary. Always discuss potential risks and benefits with the study team before joining a trial.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a novel way to enhance memory control using real-time fMRI neurofeedback. Unlike traditional methods that might involve medication or cognitive exercises, this technique directly influences brain activity by reinforcing specific neural connections between the dlPFC and hippocampus. By potentially increasing memory control ability through targeted neurofeedback, this approach offers a cutting-edge alternative to existing treatments.
What evidence suggests that this neurofeedback intervention is effective for reducing threat expectancy?
This trial will compare Active Real-time fMRI Neurofeedback with Sham Real-time fMRI Neurofeedback. Research has shown that real-time fMRI neurofeedback can calm overactive brain areas linked to memory, potentially improving memory function. Studies have found that this training can alter brain activity, particularly in regions associated with memory and emotions. The goal is to strengthen the connection between the prefrontal cortex and the hippocampus, enhancing memory control. This may improve the formation and recall of memories while reducing unwanted memories. Overall, early results suggest this method could effectively boost brain functions related to memory and threat response.678910
Who Is on the Research Team?
Kenneth A. Norman, Ph.D.
Principal Investigator
Princeton University
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 18-50 who have no history of psychiatric or neurological disorders, are not on psychoactive medications or drugs, can undergo MRI scans (no metal implants), have normal color vision, are right-handed, show spontaneous recovery behavior in a test session, and fully understand English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Neurofeedback Intervention
Participants receive real-time fMRI neurofeedback to enhance memory control ability
Follow-up
Participants are monitored for changes in spontaneous recovery behavior and neurofeedback learning
What Are the Treatments Tested in This Trial?
Interventions
- Active Real-time fMRI Neurofeedback
- Sham Real-time fMRI neurofeedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
Trustees of Princeton University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator